Overview

A Study Comparing Norspan Patch and Oral Tramadol

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This trial was designed for comparison and evaluation of the efficacy and safety of buprenorphine transdermal patch (NorspanĀ® patch 5 mg, 10 mg and 20mg) against oral tramadol (TridolĀ® SR (slow release) tablet 100mg) in patients with moderate to severe pain due to osteoarthritis.
Phase:
Phase 4
Details
Lead Sponsor:
Mundipharma Korea Ltd
Treatments:
Buprenorphine
Tramadol